Stay updated on Tagraxofusp in Secondary AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new version entry was added to the study record history, including updated study status entries and refreshed contacts/locations. This reflects ongoing administrative and recruitment updates to the trial.SummaryDifference0.1%

- Check20 days agoChange DetectedThe Record History now includes a new latest revision entry (v3.5.4) and removes the previous revision (v3.5.3) from the history list.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page’s revision identifier changes from **v3.5.2** to **v3.5.3**, indicating an update to the record-history page tooling/label rather than a modification of the clinical trial’s record details.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.5.2 was added to the history, replacing the prior v3.5.0. The previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedNew version entry dated 2026-04-08 adds Study Status updates; the history entry dated 2026-01-23 has been removed.SummaryDifference0.3%

- Check78 days agoChange DetectedA new revision entry v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.